Earnings release filed; exhibit not provided in context

TANDEM DIABETES CARE INC

2026-Q1 EPS reported -$0.30 revenue$247,221,000

Tandem Diabetes Care filed 8-K for Q1 2026 earnings.
Press release as Exhibit 99.1 was not included in this request.
No specific financial figures, guidance, or segment data available.

item 2.02 item 9.01

TANDEM DIABETES CARE INC filing history →

Source: SEC EDGAR

accession 0001438133-26-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.